from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0421c/-

LFCtreatmentdescriptionclass of inhibitor

-1.542

Amikacinug/mL Amikacintranslation

-1.649

Cap5-10ug/mL Capreomycintranslation

-2.277

Rox10-50 ug/mL Roxithromycintranslation

-1.124

SM2-5 ug/mL Streptomycintranslation

-4.639

Tet5-10 ug/mL Tetracyclinetranslation

0.487

Rif0.2-5ug/mL Rifampicintranscription

0.906

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.713

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.160

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.516

CPZ10-50 ug/mL Chlorpromazinerespiration

1.263

Clofazimine10-13 ug/mL Clofaziminerespiration

0.526

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.471

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.202

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.114

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.604

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.769

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.698

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.187

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.020

KCN5-20 ug/mL Potassium cyaniderespiration

0.772

NaN30.2-2 mM Sodium aziderespiration

0.890

Nigericin50 uM Nigericinrespiration

-0.447

TRC10-150 ug/mL Triclosanrespiration

-0.424

TRZ10-25 ug/mL Thioridazinerespiration

-1.332

Valinomycin0.5-10 uM Valinomycinrespiration

-1.362

ZnSO42 mM ZnSO4respiration

-0.214

menadione6-10 ug/mL Menadionerespiration

0.908

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.319

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.198

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.166

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.038

NRP_1Non-replicating persistence stage 1dosRassociated

0.484

Amp0.2mg/mL AmpicillincellWall

0.295

Cephalexin20-100 ug/mL CephalexincellWall

0.336

Cerulenin0.32-5 ug/mL CerulenincellWall

0.113

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.302

EMB10-20 ug/mL EthambutolcellWall

0.190

Eta12-40 ug/mL EthionamidecellWall

0.496

INH0.2-0.4 ug/mL IsoniazidcellWall

0.260

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.093

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.287

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.609

BZA0.12 mg/mL BenzamidearomaticAmides

0.181

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.195

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.830

H2O24 mM hydrogen peroxideDNAdamaging

-0.085

Levo10 ug/mL LevofloxacinDNAdamaging

0.084

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.959

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.407

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.437

UVUV-irradiationDNAdamaging

0.079

ARP41-4 ug/mL Antitubercular compound ARP4?

0.155

Antimycin12.5-50 ug/mL Antimycin A?

0.406

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.283

PA_110-50 ug/mL Antitubercular compound PA-1?

0.181

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.816

PA8240.2-2 ug/mL PA-824?

-0.053

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.572

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.531

Verapamil50 uM Verapamil?

0.254

mercaptoethanol2 mM 2-Mercaptoethanol?

0.641

methoxatin10-20 ug/mL Methoxatin?